ENAPTER AG INH O.N./ DE000A255G02 /
| 2024-05-15 8:08:14 AM | Chg. -0.1200 | Volume | Bid2:03:09 PM | Ask2:03:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.9000EUR | -2.39% | 0 Turnover: 0.0000 |
4.9400Bid Size: 200 | 5.0800Ask Size: 200 | 119.59 mill.EUR | - | - |
GlobeNewswire
2:31 PM
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Confere...
GlobeNewswire
2:30 PM
Zhibao Technology Inc. Announces Closing of Underwriters’ Over-Allotment Option in Connection with I...
GlobeNewswire
2:30 PM
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
GlobeNewswire
2:30 PM
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
GlobeNewswire
2:30 PM
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights fo...
GlobeNewswire
2:30 PM
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the A...
GlobeNewswire
2:30 PM
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double...
GlobeNewswire
2:30 PM
ALERUS FINANCIAL CORPORATION AND HMN FINANCIAL, INC. JOINTLY ANNOUNCE STRATEGIC TRANSACTION
GlobeNewswire
2:30 PM
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
2:30 PM
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
GlobeNewswire
2:30 PM
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
2:30 PM
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...
GlobeNewswire
2:30 PM
Leaders in Data Strategy Gather at Qlik Connect 2024 to Showcase AI Innovation and Results
